Access to anti-retroviral drugs, female in Mongolia
Mongolia: Access to anti-retroviral drugs, female was 36.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in Mongolia, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
The most recent figure for access to anti-retroviral drugs, female in Mongolia is 36.0%, measured in 2024.
The figure is up 44.0% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Mongolia peaked at 42.0% in 2021 and was at its lowest, 0.0%, in 2000.
That places Mongolia 130th out of 141 countries with data for 2024, putting it in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female in Mongolia, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 6.0% | — |
| 2004 | 4.0% | -33.3% |
| 2005 | 0.0% | -100.0% |
| 2006 | 0.0% | — |
| 2007 | 0.0% | — |
| 2008 | 0.0% | — |
| 2009 | 2.0% | — |
| 2010 | 7.0% | +250.0% |
| 2011 | 13.0% | +85.7% |
| 2012 | 12.0% | -7.7% |
| 2013 | 18.0% | +50.0% |
| 2014 | 25.0% | +38.9% |
| 2015 | 33.0% | +32.0% |
| 2016 | 30.0% | -9.1% |
| 2017 | 34.0% | +13.3% |
| 2018 | 33.0% | -2.9% |
| 2019 | 36.0% | +9.1% |
| 2020 | 40.0% | +11.1% |
| 2021 | 42.0% | +5.0% |
| 2022 | 40.0% | -4.8% |
| 2023 | 36.0% | -10.0% |
| 2024 | 36.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 1.2% | 0.0% | 6.0% | 10 |
| 2010s | 24.1% | 7.0% | 36.0% | 10 |
| 2020s | 38.8% | 36.0% | 42.0% | 5 |
Countries ranked near Mongolia
- 127 Syrian Arab Republic 41.0% compare
- 128 Madagascar 39.0% compare
- 129 Afghanistan 38.0% compare
- 130 Indonesia 36.0% compare
- 132 Yemen 34.0% compare
- 133 Bangladesh 33.0% compare
- 133 Congo 33.0% compare
- 133 Tunisia 33.0% compare
More gender data for Mongolia
- Child population (UN estimates and projections) 1,010 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -2.54 % change on previous year (2030)
- Age population, age 00, female, interpolated 30,279 (2025)
- Age population, age 00, male, interpolated 31,506 (2025)
- Age population, age 01, female, interpolated 31,061 (2025)
- Age population, age 01, male, interpolated 32,353 (2025)
- Age population, age 02, female, interpolated 31,994 (2025)
- Age population, age 02, male, interpolated 33,364 (2025)
- Age population, age 03, female, interpolated 33,192 (2025)
- Age population, age 03, male, interpolated 34,641 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Mongolia?
- Access to anti-retroviral drugs, female in Mongolia was 36.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Mongolia?
- The highest recorded value was 42.0% in 2021.
- What is the lowest access to anti-retroviral drugs, female recorded in Mongolia?
- The lowest recorded value was 0.0% in 2000.
- How does Mongolia rank for access to anti-retroviral drugs, female?
- Mongolia ranks 130th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Mongolia?
- Over the last ten years it is up 44.0%. The long-run trend across the full record is volatile.
- Where does this Mongolia data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.